About Womens Choice

 

 

 

Women’s Choice Pharmaceuticals is an innovative specialty pharmaceutical company whose primary focus is to provide high quality prescription products to healthcare providers in the United States. Our primary product portfolio consists of four patent protected products with market caps exceeding 500 million dollars. Our patented product portfolio, coupled with our strong company culture and nationwide professional sales force defines Women’s Choice Pharmaceuticals as an organization.

 

News

 

March 15, 2013 Wisconsin Alumni Research Foundation (WARF) and WH Nutritionals, LLC have entered into a settlement agreement wherein WH Nutritionals has agreed to cease production and sale of the Accused Products and pay WARF an undisclosed amount of money.  The patent that was involved (U.S. Patent No. 6,528,542), relating to the use of calcium formate as a dietary supplement.  FormaCal® is the branded form of calcium formate used in the Nestabs® line of prenatal vitamins.

March 12, 2013 Women’s Choice Pharmaceuticals is pleased to announce the Wisconsin Alumni Research Foundation (WARF) and Virtus Pharmaceuticals have entered into a settlement agreement wherein Virtus Pharmaceuticals has agreed to cease production and sale of the Accused Products and pay WARF an undisclosed amount of money.

December 21, 2012 Italfarmaco purchases 30% of Women's Choice Pharmaceuticals.  The partnership will allow Italfarmaco to commercialize its Women's Health division the United States.  Italfarmaco is a privately held Italian company specializing in Oncology and Women's Health.  They do business in more than 40 countries and have sales over $650 million.

December 12, 2012 Wisconsin Alumni Research Foundation (WARF) filed suit against Virtus Pharmaceuticals for patent infringement on United States Patent No. 6,528,542, entitled "Calcium Formate for Use as a Dietary Supplement." Women's Choice utilizes the patented Calcium Formate in its Nestabs® line.

December 7 2012, Women's Choice Pharmaceuticals is delighted that today the Wisconsin Alumni Research Foundation (WARF), a non-profit organization for the University of Wisconsin filed a law suit against WH Nutritionals, LLC for patent infringement on United States Patent No. 6,528,542, entitled "Calcium Formate for Use as a Dietary Supplement."  Women's Choice utilizes the patented Calcium Formate in its Nestabs® line.

February 2010, Launched three patented products: Nestabs® DHA,  Nestabs®, Irospan® 24/6

December 2010, Recruited and hired 35 experienced pharmaceuticals sales professionals

October 2010, Negotiated and secured a manufacturing agreement for the commercial production of ProCort®

Invisicare® – a patented M1 polymer delivery system

April 2010, Signed a development Agreement with Skinvisible

FormiCal® – a patented and branded form of calcium formate: ®

September 2009, Established a license agreement with Nephro-Tech LLC